Oswald, Ailsa J.
Berg, Kathryn
Ralston, Stuart H.
Riches, Philip L. http://orcid.org/0000-0003-3029-7098
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 13 February 2019
Accepted: 6 May 2019
First Online: 21 May 2019
Compliance with Ethical Standards
:
: This work was supported by an unrestricted educational grant made by Eli Lilly to the Rheumatic Diseases Unit, University of Edinburgh. Stuart H. Ralston has participated in an independent data monitoring committee for Novartis, and has recruited to clinical trials on behalf of Amgen, Eli Lilly and Pfizer. Ailsa J. Oswald, Kathryn Berg, and Philip L. Riches have no further conflict of interest to declare.
: This was a retrospective audit of normal clinical care. Following discussion with NHS Lothian Research Office, it was agreed that formal ethical approval was not required.